116 related articles for article (PubMed ID: 20719476)
1. Searching for the role of membrane sphingolipids in selectivity of antitumor ether lipid-edelfosine.
Hac-Wydro K; Dynarowicz-Łatka P
Colloids Surf B Biointerfaces; 2010 Dec; 81(2):492-7. PubMed ID: 20719476
[TBL] [Abstract][Full Text] [Related]
2. The relationship between the concentration of ganglioside GM1 and antitumor activity of edelfosine--the Langmuir monolayer study.
Hac-Wydro K; Dynarowicz-Łatka P
Colloids Surf B Biointerfaces; 2010 Nov; 81(1):385-8. PubMed ID: 20692132
[TBL] [Abstract][Full Text] [Related]
3. Edelfosine disturbs the sphingomyelin-cholesterol model membrane system in a cholesterol-dependent way - the Langmuir monolayer study.
Hąc-Wydro K; Dynarowicz-Łątka P; Wydro P; Bąk K
Colloids Surf B Biointerfaces; 2011 Dec; 88(2):635-40. PubMed ID: 21862295
[TBL] [Abstract][Full Text] [Related]
4. Edelfosine in membrane environment - the Langmuir monolayer studies.
Dynarowicz-Latka P; Hac-Wydro K
Anticancer Agents Med Chem; 2014 May; 14(4):499-508. PubMed ID: 24628234
[TBL] [Abstract][Full Text] [Related]
5. Langmuir monolayer study toward combined antileishmanian therapy involving amphotericin B and edelfosine.
Hac-Wydro K; Dynarowicz-Łatka P; Zuk R
J Phys Chem B; 2009 Oct; 113(43):14239-46. PubMed ID: 19845406
[TBL] [Abstract][Full Text] [Related]
6. Edelfosine is incorporated into rafts and alters their organization.
Ausili A; Torrecillas A; Aranda FJ; Mollinedo F; Gajate C; Corbalán-García S; de Godos A; Gómez-Fernández JC
J Phys Chem B; 2008 Sep; 112(37):11643-54. PubMed ID: 18712919
[TBL] [Abstract][Full Text] [Related]
7. Effect of edelfosine on tumor and normal cells model membranes--a comparative study.
Hac-Wydro K; Dynarowicz-Łatka P
Colloids Surf B Biointerfaces; 2010 Mar; 76(1):366-9. PubMed ID: 19896813
[TBL] [Abstract][Full Text] [Related]
8. In vitro and In vivo selective antitumor activity of Edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts.
Mollinedo F; de la Iglesia-Vicente J; Gajate C; Estella-Hermoso de Mendoza A; Villa-Pulgarin JA; de Frias M; Roué G; Gil J; Colomer D; Campanero MA; Blanco-Prieto MJ
Clin Cancer Res; 2010 Apr; 16(7):2046-54. PubMed ID: 20233887
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of K562 and HL-60 cells to edelfosine, an ether lipid drug, correlates with production of reactive oxygen species.
Wagner BA; Buettner GR; Oberley LW; Burns CP
Cancer Res; 1998 Jul; 58(13):2809-16. PubMed ID: 9661895
[TBL] [Abstract][Full Text] [Related]
10. Proapoptotic role of Hsp90 by its interaction with c-Jun N-terminal kinase in lipid rafts in edelfosine-mediated antileukemic therapy.
Nieto-Miguel T; Gajate C; González-Camacho F; Mollinedo F
Oncogene; 2008 Mar; 27(12):1779-87. PubMed ID: 17891170
[TBL] [Abstract][Full Text] [Related]
11. Interactions between single-chained ether phospholipids and sphingomyelin in mixed monolayers at the air/water interface-Grazing incidence X-ray diffraction and Brewster angle microscopy studies.
Flasiński M; Hąc-Wydro K; Wydro P; Broniatowski M; Dynarowicz-Łątka P
Colloids Surf B Biointerfaces; 2013 Nov; 111():43-51. PubMed ID: 23777791
[TBL] [Abstract][Full Text] [Related]
12. Effect of anti-tumor ether lipids on ordered domains in model membranes.
Heczková B; Slotte JP
FEBS Lett; 2006 May; 580(10):2471-6. PubMed ID: 16638573
[TBL] [Abstract][Full Text] [Related]
13. Surface-active properties of the antitumour ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (edelfosine).
Busto JV; Sot J; Goñi FM; Mollinedo F; Alonso A
Biochim Biophys Acta; 2007 Jul; 1768(7):1855-60. PubMed ID: 17543274
[TBL] [Abstract][Full Text] [Related]
14. Lipid rafts, endoplasmic reticulum and mitochondria in the antitumor action of the alkylphospholipid analog edelfosine.
Gajate C; Mollinedo F
Anticancer Agents Med Chem; 2014 May; 14(4):509-27. PubMed ID: 24628241
[TBL] [Abstract][Full Text] [Related]
15. Lipid raft-targeted therapy in multiple myeloma.
Mollinedo F; de la Iglesia-Vicente J; Gajate C; Estella-Hermoso de Mendoza A; Villa-Pulgarin JA; Campanero MA; Blanco-Prieto MJ
Oncogene; 2010 Jul; 29(26):3748-57. PubMed ID: 20418917
[TBL] [Abstract][Full Text] [Related]
16. Fluorescent phenylpolyene analogues of the ether phospholipid edelfosine for the selective labeling of cancer cells.
Quesada E; Delgado J; Gajate C; Mollinedo F; Acuña AU; Amat-Guerri F
J Med Chem; 2004 Oct; 47(22):5333-5. PubMed ID: 15481970
[TBL] [Abstract][Full Text] [Related]
17. Involvement of lipid rafts in the localization and dysfunction effect of the antitumor ether phospholipid edelfosine in mitochondria.
Mollinedo F; Fernández M; Hornillos V; Delgado J; Amat-Guerri F; Acuña AU; Nieto-Miguel T; Villa-Pulgarín JA; González-García C; Ceña V; Gajate C
Cell Death Dis; 2011 May; 2(5):e158. PubMed ID: 21593790
[TBL] [Abstract][Full Text] [Related]
18. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L).
Mollinedo F; Fernández-Luna JL; Gajate C; Martín-Martín B; Benito A; Martínez-Dalmau R; Modolell M
Cancer Res; 1997 Apr; 57(7):1320-8. PubMed ID: 9102220
[TBL] [Abstract][Full Text] [Related]
19. Towards the understanding of the behavior of single-chained ether phospholipids in model biomembranes: interactions with phosphatidylethanolamines in Langmuir monolayers.
Hąc-Wydro K; Flasiński M; Wydro P; Dynarowicz-Łątka P
Colloids Surf B Biointerfaces; 2012 Sep; 97():162-70. PubMed ID: 22609598
[TBL] [Abstract][Full Text] [Related]
20. Anticancer Agent Edelfosine Exhibits a High Affinity for Cholesterol and Disorganizes Liquid-Ordered Membrane Structures.
Ausili A; Martínez-Valera P; Torrecillas A; Gómez-Murcia V; de Godos AM; Corbalán-García S; Teruel JA; Gómez Fernández JC
Langmuir; 2018 Jul; 34(28):8333-8346. PubMed ID: 29924618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
